Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 27, 2024	Mar. 29, 2023
Cash flows from operating activities:
Net income	$ 4,691	$ 597
Adjustments to reconcile net income to cash flows provided by operating activities:
Depreciation and amortization	3,581	3,656
Operating (gains), losses and other charges, net	(327)	(1,329)
Losses and amortization on interest rate swaps, net	141	10,662
Amortization of deferred financing costs	159	159
Gains on investments	(6)	(5)
Losses on early termination of debt and leases	123	0
Deferred income tax (benefit) expense	(768)	133
Decrease of tax valuation allowance	(26)	0
Share-based compensation expense	2,776	3,094
Changes in assets and liabilities, excluding acquisitions and dispositions:
Receivables	4,011	1,814
Inventories	102	2,284
Prepaids and other current assets	3,208	2,652
Other noncurrent assets	860	1,119
Operating lease assets and liabilities	(164)	(246)
Accounts payable	(11,037)	(1,131)
Other accrued liabilities	(6,408)	(6,534)
Other noncurrent liabilities	(701)	(772)
Net cash flows provided by operating activities	215	16,153
Cash flows from investing activities:
Capital expenditures	(4,905)	(1,304)
Proceeds from sales of real estate and other assets	986	1,715
Investment purchases	(1,500)	(1,300)
Collections on notes receivable	171	320
Issuance of notes receivable	(79)	0
Net cash flows used in investing activities	(5,327)	(569)
Cash flows from financing activities:
Revolver borrowings	52,200	35,000
Revolver payments	(46,500)	(32,500)
Repayments of finance leases	(370)	(506)
Tax withholding on share-based payments	(1,872)	(2,846)
Purchase of treasury stock	(4,774)	(9,041)
Net bank overdrafts	2,699	(319)
Net cash flows provided by (used in) financing activities	1,383	(10,212)
(Decrease) increase in cash and cash equivalents	(3,729)	5,372
Cash and cash equivalents at beginning of period	4,893	3,523
Cash and cash equivalents at end of period	$ 1,164	$ 8,895